Wellington Management Group
EIGR

Wellington Management Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Wellington Management Group’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,079
Closed -$1.06M – 2323
2017
Q1 		$1.06M Sell
3,079
-6,174
-67% -$2.13M ﹤0.01% 1909
2016
Q4 		$3.23M Sell
9,253
-575
-6% -$211K ﹤0.01% 1554
2016
Q3 		$3.95M Buy
9,828
+5,911
+151% +$3.02M ﹤0.01% 1463
2016
Q2 		$2.33M Buy
3,917
+3,292
+527% +$2M ﹤0.01% 1569
2016
Q1 		$315K Buy
+625
New +$311K ﹤0.01% 2023

Other funds holding EIGR

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

Wellington Management Group's EIGR Position: Q2 2017 in Review

Wellington Management Group sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2017, closing a stake of 3,079 shares — an estimated $1.06M sold.

Wellington Management Group first reported a position in EIGR in Q1 2016 and held it in 5 quarters. The position peaked at $3.95M in Q3 2016. 39 funds tracked by Wall St. Rank hold EIGR as of Q2 2017.

  • Wellington Management Group reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Wellington Management Group sold 3,079 Eiger BioPharmaceuticals, Inc. shares in Q2 2017, an estimated $1.06M.
  • Wellington Management Group first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2016 and held it in 5 quarters.
  • Wellington Management Group's Eiger BioPharmaceuticals, Inc. position peaked at $3.95M in Q3 2016.
  • 39 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2017.

Based on Wellington Management Group's 13F filing for Q2 2017, filed 14 Aug 2017.